KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Amgen (AMGN) over the last 15 years, with Q3 2025 value amounting to $1.3 billion.

  • Amgen's Dividends Paid - Common rose 595.04% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 585.27%. This contributed to the annual value of $4.8 billion for FY2024, which is 605.79% up from last year.
  • According to the latest figures from Q3 2025, Amgen's Dividends Paid - Common is $1.3 billion, which was up 595.04% from $1.3 billion recorded in Q2 2025.
  • Amgen's 5-year Dividends Paid - Common high stood at $1.3 billion for Q3 2025, and its period low was $990.0 million during Q4 2021.
  • Its 5-year average for Dividends Paid - Common is $1.1 billion, with a median of $1.1 billion in 2023.
  • As far as peak fluctuations go, Amgen's Dividends Paid - Common surged by 297.62% in 2022, and later soared by 982.66% in 2023.
  • Quarter analysis of 5 years shows Amgen's Dividends Paid - Common stood at $990.0 million in 2021, then increased by 5.05% to $1.0 billion in 2022, then rose by 9.62% to $1.1 billion in 2023, then increased by 5.7% to $1.2 billion in 2024, then increased by 6.39% to $1.3 billion in 2025.
  • Its Dividends Paid - Common was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.